NCT00182208

Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 32 (planned)
• Sponsor: Hamilton Health Sciences Corporation · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether daily use of a lower limb venous-return assist device, "Venowave', improves leg symptoms, ability to perform activities of daily living, and quality of life in subjects with severe PTS.

Detailed description

Eligible consenting patients will be randomly allocated to receive either the veno-device (active or placebo for 8 weeks and crossed over for a further 8 weeks (active or placebo) following a 4 week 'wash out' period.( A randomized controlled 'crossover' study}

Conditions

• Postphlebitic Syndrome

Interventions

Type	Name	Description
DEVICE	Veno-device (Venowave)

Timeline

• Start date: 2004-05-01
• Primary completion: 2005-06-01
• Completion: 2005-12-01
• First posted: 2005-09-16
• Last updated: 2008-07-22

Locations

2 sites across 1 country: Canada